CIRCADIAN VARIATION OF SUSTAINED VENTRICULAR-TACHYCARDIA IN PATIENTS WITH CORONARY-ARTERY DISEASE AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS

被引:100
|
作者
LAMPERT, R [1 ]
ROSENFELD, L [1 ]
BATSFORD, W [1 ]
LEE, F [1 ]
MCPHERSON, C [1 ]
机构
[1] YALE UNIV,YALE NEW HAVEN HOSP,SCH MED,NEW HAVEN,CT 06504
关键词
CIRCADIAN RHYTHM; DEATH; SUDDEN; DEFIBRILLATION; TACHYCARDIA;
D O I
10.1161/01.CIR.90.1.241
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background While previous studies using epidemiological data and ambulatory ECG monitoring have shown peak occurrence of sudden death and nonsustained ventricular tachycardia in the morning, none have examined circadian variation of potentially life-threatening ventricular tachycardia (VT), nor has any study observed circadian behavior of any arrhythmias in individuals followed longitudinally. We used the event memory of multiprogrammable implantable cardioverter-defibrillators to evaluate the circadian pattern of sustained VT over time. Methods and Results Data were reviewed from 32 consecutive patients with coronary artery disease and sustained VT who had received the Ventak PRX (CPI, Inc) cardioverter-defibrillator between May 1991 and August 1993 and had experienced at least one episode of VT terminated by their device. Mean follow-up was 14+/-7 months. Among the 2558 episodes recorded by the device logs, VT occurrence peaked between 6 AM and noon (P=.007 by ANOVA among four 6-hour time periods). Harmonic regression revealed a morning peak at 9 AM (P<.01). This morning peak occurred in patients with both frequent and infrequent events. Among 21 patients who experienced more than four VT events, 8 (38%) had an AM peak of VT occurrence (>35% of VT between 6 AM and noon). Neither age, ejection fraction, event frequency, presenting arrhythmia, nor drug therapy distinguished patients who displayed the AM VT peak. Conclusions In patients with coronary artery disease, sustained VT displays circadian variation with peak frequency in the morning, similar to that for sudden death. Individual patients who display specific patterns of circadian variation over time can be identified using defibrillator logs. Investigation of circadian variation of other phenomena to elucidate mechanisms of VT should focus on these patients.
引用
收藏
页码:241 / 247
页数:7
相关论文
共 42 条
  • [1] LONG-TERM REPRODUCIBILITY OF VENTRICULAR-TACHYCARDIA INDUCTION IN PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS - SERIAL NONINVASIVE STUDIES
    GILLIS, AM
    SHELDON, RS
    WYSE, G
    LEITCH, JW
    YEE, R
    KLEIN, GJ
    DUFF, HJ
    MITCHELL, LB
    CIRCULATION, 1995, 91 (10) : 2605 - 2613
  • [2] Predictors of Mortality in Patients with Chagas' Cardiomyopathy and Ventricular Tachycardia Not Treated with Implantable Cardioverter-Defibrillators
    Lima Sarabanda, Alvaro Valentim
    Marin-Neto, Jose Antonio
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2011, 34 (01): : 54 - 62
  • [3] RADIOFREQUENCY CATHETER ABLATION OF VENTRICULAR-TACHYCARDIA IN PATIENTS WITH CORONARY-ARTERY DISEASE
    MORADY, F
    HARVEY, M
    KALBFLEISCH, SJ
    ELATASSI, R
    CALKINS, H
    LANGBERG, JJ
    CIRCULATION, 1993, 87 (02) : 363 - 372
  • [4] The Effect of Spironolactone on Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter-Defibrillators
    Zarraga, Ignatius Gerardo E.
    Dougherty, Cynthia M.
    MacMurdy, Karen S.
    Raitt, Merritt H.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2012, 5 (04) : 739 - 747
  • [5] Destabilizing effects of mental stress on ventricular arrhythmias in patients with implantable cardioverter-defibrillators
    Lampert, R
    Jain, D
    Burg, MM
    Batsford, WP
    McPherson, CA
    CIRCULATION, 2000, 101 (02) : 158 - 164
  • [6] Comparison of d,l-sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease
    Bocker, D
    Haverkamp, W
    Block, M
    Borggrefe, M
    Hammel, D
    Breithardt, G
    CIRCULATION, 1996, 94 (02) : 151 - 157
  • [7] Subcutaneous Implantable Cardioverter-Defibrillators in Patients With Congenital Heart Disease
    Waldmann, Victor
    Marquie, Christelle
    Bessiere, Francis
    Perrot, David
    Anselme, Frederic
    Badenco, Nicolas
    Barra, Sergio
    Bertaux, Geraldine
    Blangy, Hugues
    Bordachar, Pierre
    Boveda, Serge
    Chauvin, Michel
    Clementy, Nicolas
    Clerici, Gael
    Combes, Nicolas
    Defaye, Pascal
    Deharo, Jean-Claude
    Durand, Philippe
    Duthoit, Guillaume
    Eschalier, Romain
    Fauchier, Laurent
    Garcia, Rodrigue
    Geoffroy, Olivier
    Gitenay, Edouard
    Gourraud, Jean-Baptiste
    Guenancia, Charles
    Iserin, Laurence
    Jacon, Peggy
    Jesel-Morel, Laurence
    Kerkouri, Fawzi
    Klug, Didier
    Koutbi, Linda
    Labombarda, Fabien
    Ladouceur, Magalie
    Laurent, Gabriel
    Leclercq, Christophe
    Maille, Baptiste
    Maltret, Alice
    Massoulie, Gregoire
    Mondoly, Pierre
    Ninni, Sandro
    Ollitrault, Pierre
    Pasquie, Jean-Luc
    Pierre, Bertrand
    Pujadas, Penelope
    Champ-Rigot, Laure
    Sacher, Frederic
    Sadoul, Nicolas
    Schatz, Alexandre
    Winum, Pierre
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (07) : 590 - 599
  • [8] The Extent of Left Ventricular Scar Quantified by Late Gadolinium Enhancement MRI Is Associated With Spontaneous Ventricular Arrhythmias in Patients With Coronary Artery Disease and Implantable Cardioverter-Defibrillators
    Scott, Paul A.
    Morgan, John M.
    Carroll, Nicola
    Murday, David C.
    Roberts, Paul R.
    Peebles, Charles R.
    Harden, Stephen P.
    Curzen, Nick P.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2011, 4 (03) : 324 - 330
  • [9] Revascularization versus implantable cardioverter-defibrillators to prevent sudden death in patients with severe left ventricular dysfunction
    Weintraub, WS
    CIRCULATION, 2001, 104 (13) : 1457 - 1458
  • [10] Predictors of mortality and heart transplantation in patients with Chagas' cardiomyopathy and ventricular tachycardia treated with implantable cardioverter-defibrillators: commentary
    Martinelli Filho, Martino
    EUROPACE, 2019, 21 (07): : 999 - 1000